Cite
HARVARD Citation
Mitwasi, N. et al. (n.d.). 45P The RevCAR T cell platform: A switchable and combinatorial therapeutic strategy for glioblastoma. Immuno-oncology technology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mitwasi, N. et al. (n.d.). 45P The RevCAR T cell platform: A switchable and combinatorial therapeutic strategy for glioblastoma. Immuno-oncology technology. p. . [Online].